N/A
Manufactured by ARMY AND AIR FORCE EXCHANGE SERVICE
13 FDA adverse event reports analyzed
Last updated: 2026-04-15
ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by ARMY AND AIR FORCE EXCHANGE SERVICE. The most commonly reported adverse reactions for ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE include ANXIETY, CRYING, DIZZINESS, DRUG INEFFECTIVE, DYSPNOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE.
Out of 4 classified reports for ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 13 FDA FAERS reports that mention ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ANXIETY, CRYING, DIZZINESS, DRUG INEFFECTIVE, DYSPNOEA, ENERGY INCREASED. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list ARMY AND AIR FORCE EXCHANGE SERVICE in connection with ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE. Always verify the specific product and NDC with your pharmacist.